First inhibitor for enzyme linked to cancers created

20 noviembre 2014

Recent studies showing acid ceramidase (AC) to be upregulated in melanoma, lung and prostate cancers have made the enzyme a desired target for novel synthetic inhibitor compounds. Now scientists describe the very first class of AC inhibitors that may aid in the efficacy of chemotherapies.